Lundbeck
HLUN-B.CO
#2813
Rank
C$8.85 B
Marketcap
C$8.92
Share price
-1.05%
Change (1 day)
2.70%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2026 (TTM): C$1.05

According to Lundbeck's latest financial reports the company's current EPS (TTM) is C$1.04. In 2025 the company made an earnings per share (EPS) of C$0.70 an increase over its 2024 EPS that were of C$0.61.

EPS history for Lundbeck from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$1.0548.71%
2025C$0.7014.5%
2024C$0.6129.29%
2023C$0.4823.09%
2022C$0.3937.26%
2021C$0.28-84.61%
2020C$1.83-24.61%
2019C$2.43-42.06%
2018C$4.1940.7%
2017C$2.98146.26%
2016C$1.21-120.48%
2015C-$5.903231.32%
2014C-$0.18-115.78%
2013C$1.12-23.36%
2012C$1.46-48.01%
2011C$2.82-9.68%
2010C$3.1213.72%
2009C$2.7424.32%
2008C$2.21-6.05%
2007C$2.3581.77%
2006C$1.29-16.76%
2005C$1.55-17.58%
2004C$1.88